An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the difference in preventing a relapse between
Betaseron and Avonex. Patients with RRMS currently treated with Avonex will be randomized
into 2 equal-size arms; one arm will continue on the standard dose of Avonex; one arm will be
converted to Betaseron standard dose.